AI Article Synopsis

  • Elevated annexin A6 (AnxA6) levels were found in Niemann-Pick-type C1 (NPC1) mutant cells, and reducing AnxA6 helped alleviate cholesterol accumulation due to NPC1 deficiency.
  • AnxA6 accumulation was linked to poor protein degradation rather than increased production, suggesting a disruption in the chaperone-mediated autophagy (CMA) pathway affecting cholesterol regulation.
  • Overexpressing lysosome-associated membrane protein 2A (Lamp2A) in NPC1 mutant cells reduced both AnxA6 levels and cholesterol in lysosomes, indicating that Lamp2A could restore CMA function and improve cholesterol balance in these cells.

Article Abstract

We recently identified elevated annexin A6 (AnxA6) protein levels in Niemann-Pick-type C1 (NPC1) mutant cells. In these cells, AnxA6 depletion rescued the cholesterol accumulation associated with NPC1 deficiency. Here, we demonstrate that elevated AnxA6 protein levels in NPC1 mutants or upon pharmacological NPC1 inhibition, using U18666A, were not due to upregulated AnxA6 mRNA expression, but caused by defects in AnxA6 protein degradation. Two KFERQ-motifs are believed to target AnxA6 to lysosomes for chaperone-mediated autophagy (CMA), and we hypothesized that the cholesterol accumulation in endolysosomes (LE/Lys) triggered by the NPC1 inhibition could interfere with the CMA pathway. Therefore, AnxA6 protein amounts and cholesterol levels in the LE/Lys (LE-Chol) compartment were analyzed in NPC1 mutant cells ectopically expressing lysosome-associated membrane protein 2A (Lamp2A), which is well known to induce the CMA pathway. Strikingly, AnxA6 protein amounts were strongly decreased and coincided with significantly reduced LE-Chol levels in NPC1 mutant cells upon Lamp2A overexpression. Therefore, these findings suggest Lamp2A-mediated restoration of CMA in NPC1 mutant cells to lower LE-Chol levels with concomitant lysosomal AnxA6 degradation. Collectively, we propose CMA to permit a feedback loop between AnxA6 and cholesterol levels in LE/Lys, encompassing a novel mechanism for regulating cholesterol homeostasis in NPC1 disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291204PMC
http://dx.doi.org/10.3390/cells9051152DOI Listing

Publication Analysis

Top Keywords

npc1 mutant
20
mutant cells
20
anxa6 protein
20
cholesterol levels
12
npc1
10
anxa6
10
feedback loop
8
protein levels
8
cholesterol accumulation
8
levels npc1
8

Similar Publications

NPC1 controls TGFBR1 stability in a cholesterol transport-independent manner and promotes hepatocellular carcinoma progression.

Nat Commun

January 2025

State Key Laboratory of Medical Proteomics, National Center for Protein Sciences (Beijing), Beijing Proteome Research Center, Beijing Institute of Lifeomics, Beijing, China.

Niemann-Pick disease type C protein 1 (NPC1), classically associated with cholesterol transport and viral entry, has an emerging role in cancer biology. Here, we demonstrate that knockout of Npc1 in hepatocytes attenuates hepatocellular carcinoma (HCC) progression in both DEN (diethylnitrosamine)-CCl induced and MYC-driven HCC mouse models. Mechanistically, NPC1 significantly promotes HCC progression by modulating the TGF-β pathway, independent of its traditional role in cholesterol transport.

View Article and Find Full Text PDF

Two NPC1 homologous proteins are involved in asexual reproduction, pathogenicity, and lipid trafficking in Phytophthora sojae.

Int J Biol Macromol

January 2025

Department of Plant Pathology, College of Plant Protection, China Agricultural University, Beijing, China; State Key Laboratory of Crop Stress Biology for Arid Areas, College of Plant Protection, Northwest A&F University, Yangling, China. Electronic address:

Niemann-Pick type C (NPC) disease is characterized by lysosomal lipid storage disorders and defects in lipid trafficking, primarily due to mutations in the NPC1 protein. Two NPC1 homologous proteins are present in the genome of Phytophthora sojae, named as PsNPC1-1 and PsNPC1-2. Both proteins exhibit high sequence identity, consistent conserved functional domains, similar gene expression patterns, and comparable subcellular localization.

View Article and Find Full Text PDF
Article Synopsis
  • - Niemann-Pick type C disease is caused mainly by mutations in the NPC1 gene, leading to cholesterol buildup and lysosomal dysfunction.
  • - The study tested polyphenol-rich extracts from *L.* (RCME) and its components, rutin and quercitrin, to see if they could improve NPC1 protein trafficking and reduce cholesterol levels in NPC patient-derived fibroblasts, finding that RCME was effective while the drug miglustat was not.
  • - RCME was shown to improve the trafficking of various NPC1 mutants and lower cholesterol levels, suggesting it may be a more effective therapeutic option than current treatments that only reduce cholesterol levels.
View Article and Find Full Text PDF
Article Synopsis
  • Scientists are looking for medicines that can help fix problems caused by bad versions of proteins in diseases, especially for Niemann-Pick type C1 disease, which affects how cholesterol moves in cells and can cause serious health issues.
  • They studied special human brain cells with different types of NPC1 mutations (the bad protein) to find small drugs that could help the protein work better.
  • They found a drug called mo56-hydroxycholesterol that helps these mutant proteins and created mice with a common mutation to better understand the disease and test the drug's effects.
View Article and Find Full Text PDF

Npc1 deficiency impairs microglia function via TREM2-mTOR signaling in Niemann-Pick disease type C.

Biochim Biophys Acta Mol Basis Dis

December 2024

Stem Cells and Biotherapy Engineering Research Center of Henan, National Joint Engineering Laboratory of Stem Cells and Biotherapy, School of Life Science and Technology, Xinxiang Medical University, Xinxiang, China; Henan Joint International Research Laboratory of Stem Cell Medicine, School of Medical Engineering, Xinxiang Medical University, Xinxiang, China. Electronic address:

Article Synopsis
  • - Niemann-Pick disease Type C (NPC) is a neurodegenerative disorder caused by mutations in the NPC1 gene, resulting in cholesterol buildup in cells, particularly affecting microglial function.
  • - In neonatal Npc1 mutant mice, researchers observed reactive microglia with increased CD68 and phagocytic activity, indicating disrupted TREM2-mTOR signaling pathways.
  • - The study found that deleting the Trem2 gene in Npc1-deficient BV2 cells partially restored microglial function, suggesting that NPC1 loss alters microglial morphology and lysosomal function via TREM2-mTOR signaling.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!